Filing Details
- Accession Number:
- 0001493152-21-003209
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-10 07:13:16
- Reporting Period:
- 2021-02-08
- Accepted Time:
- 2021-02-10 07:13:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1433607 | Inspiremd Inc. | NSPR | Surgical & Medical Instruments & Apparatus (3841) | 262123838 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1796908 | Marvin Slosman | C/O Inspiremd, Inc. 4 Menorat Hamaor St. Tel Aviv L3 6744832 | Ceo And President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-02-08 | 40,320 | $0.62 | 1,453,538 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrants | Acquisiton | 2021-02-08 | 20,160 | $0.62 | 20,160 | $0.68 |
Common Stock | Options (right to buy) | Acquisiton | 2020-08-31 | 391,762 | $0.00 | 391,762 | $0.39 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
75,710 | 2021-02-08 | 2026-02-08 | No | 4 | P | Direct |
452,556 | 2030-08-31 | No | 4 | A | Direct |
Footnotes
- The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 40,320 shares of common stock and warrants to purchase 20,160 shares of common stock together, as part of 40,320 units, at a purchase price of $0.62 per unit.
- The Reporting Person has not engaged in any reportable transactions with respect to these derivative securities of the Issuer and is including his ownership of these securities for informational purposes only in this Form 4.
- The options vest and become exercisable in three equal installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service.